Weekly US prescriptions for Novo's Wegovy pill hit a record 217,050
MedWatch reports a 4.2% weekly rise, the highest level for the oral weight loss pill since it launched earlier this year.
Recap by typeshit. Full story at MedWatch.
MedWatch reports a 4.2% weekly rise, the highest level for the oral weight loss pill since it launched earlier this year.
Recap by typeshit. Full story at MedWatch.
Tara Wider has spent about five years posting on holistic beauty and women's wellness, building a following of women her age on social media.
Brown says diet and exercise still matter, but argues that shaming people for treating obesity with medication has never made anyone healthier.
A short share on growing GLP-1 use in the US, with no figures or sources attached. Thin on detail beyond the headline itself.
A new survey covered by Chain Store Age tracks how GLP-1 users are shifting their food spending from restaurants toward grocery stores.
Fractyl's new catheter patent runs to 2042 as the company heads toward an FDA De Novo submission, backed by its positive six-month REMAIN-1 results.
The AGS guidance is meant to help clinicians prescribe obesity medications safely and with a patient-centered approach for older people.
Loading…